LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
31 funds hold it · Insiders net selling
Net selling: insiders sold $26.8M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 5, 2026
Period ending
Sep 30, 2026
Earnings per share
-$0.17 expected
Estimates as of Nov 11, 2026
EPS expected
-$1.14 to -$1.04
Revenue expected
7 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 5, 2026 | $0.49est. -$0.17 | +$0.66beat | $5.14BSEC filing | +72.1%from $2.99B |
| Jun 30, 2026Reported Aug 6, 2026 | $1.10est. $0.38 | +$0.72beat | $4.88BSEC filing | +70.4%from $2.86B |
| Mar 31, 2026Reported May 6, 2026 | $2.07est. $1.10 | +88.18%beat | $4.65BSEC filing | +52.6%from $3.05B |
| Dec 31, 2025Reported Feb 10, 2026 | -$1.24est. -$0.92 | -34.58%miss | $2.81BAlpha Vantage | +17.3%from $2.39B |
| Sep 30, 2025Reported Nov 6, 2025 | -$0.53est. -$0.58 | +8.62%beat | $2.99BSEC filing | +23.2%from $2.42B |
| Jun 30, 2025Reported Aug 6, 2025 | -$0.89est. -$0.84 | -5.95%miss | $2.86BSEC filing | +29.0%from $2.22B |
| Mar 31, 2025Reported May 7, 2025 | $0.92est. $0.81 | +13.58%beat | $3.05BSEC filing | +42.2%from $2.14B |
| Dec 31, 2024Reported Feb 4, 2025 | -$0.62est. -$0.58 | -6.90%miss | $2.39BAlpha Vantage | +67.1%from $1.43B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.81B | $4.65B | $4.88B | $5.14B |
| Cost of what it sold | $2.62B | $3.23B | — | $4.23B |
| Gross profit | $185.2M | $1.42B | $4.88B | $906.5M |
| What it spent | ||||
| Sales and admin | $511.0M | $160.1M | $176.9M | $721.9M |
| Other operating costs | $7.9M | $553.2M | $4.32B | — |
| Total operating expenses | $518.9M | $713.3M | $4.50B | $728.4M |
| What was left | ||||
| Operating profit | -$333.7M | $704.1M | $383.0M | $178.0M |
| Interest on debt | $1.1M | $5.4M | $4.7M | $4.7M |
| Profit before tax | -$352.7M | $698.8M | $383.0M | $175.4M |
| Tax | -$247.0K | $19.8M | $21.2M | $8.1M |
| Net profit | -$352.6M | $679.0M | $361.8M | $167.3M |
| EBITDA | -$346.1M | $711.1M | $393.8M | $186.7M |
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is neutral
Form 8K Oscar Health Inc For: 5 November By Investing.com
NeutralNov 5Oscar Health - Class A Share News - Latest Updates, Live News & More
NeutralNov 136 macro signals shaping OSCR right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
